DrugPatentWatch Database Preview
Drugs in Development Information for Palifosfamide
» See Plans and Pricing
What is the development status for investigational drug Palifosfamide?
Palifosfamide is an investigational drug.
There have been 8 clinical trials for Palifosfamide.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2010.
The most common disease conditions in clinical trials are Testicular Neoplasms, Sarcoma, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are Ziopharm, Indiana University School of Medicine, and [disabled in preview].
Summary for Palifosfamide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 22 |
| WIPO Patent Applications | 210 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2010-07-01) |
| Vendors | 32 |
Recent Clinical Trials for Palifosfamide
| Title | Sponsor | Phase |
|---|---|---|
| Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. | Ziopharm | Phase 2 |
| Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors | Ziopharm | Phase 2 |
| Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors | Indiana University School of Medicine | Phase 2 |
Clinical Trial Summary for Palifosfamide
Top disease conditions for Palifosfamide
Top clinical trial sponsors for Palifosfamide
US Patents for Palifosfamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
